Importantly, this effect was driven by BRAF class 1 mutated samples that showed a significant overrepresentation (adjusted P < 0.001, Fisher's exact test with Benjamini–Hochberg correction) of MSI‐H samples in comparison to RAS/BRAF‐wt samples in all CRC cases. This evidence concerns the gene BRAF and colorectal carcinoma.